We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
(+271%)
Cap. Flow
+$1.53B
Cap. Flow
% of AUM
16.94%
Top 10 Holdings %
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$487M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$48.2M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$29.4M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$28.9M |
| 5 |
Microsoft
MSFT
|
+$27.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$51.8M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$38.5M |
| 3 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$32.6M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$21M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$16.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.25% |
| 2 | Industrials | 4.6% |
| 3 | Consumer Discretionary | 4.31% |
| 4 | Healthcare | 4.26% |
| 5 | Financials | 3.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SI
2351
DELISTED
Silvergate Capital Corporation
SI
| $251K | ﹤0.01% |
17,490
+12,681
| +264% | +$182K |
|
2352
Franco-Nevada
FNV
$44.7B
| $250K | ﹤0.01% |
1,792
+1,236
| +222% | +$184K |
|
2353
Kimco Realty
KIM
$16.4B
| $250K | ﹤0.01% |
22,193
+5,328
| +32% | +$62.9K |
|
2354
Personalis
PSNL
$1.54B
| $250K | ﹤0.01% |
11,566
+6,538
| +130% | +$130K |
|
2355
Sierra Bancorp
BSRR
$532M
| $249K | ﹤0.01% |
14,853
+12,364
| +497% | +$221K |
|
2356
NNN REIT
NNN
$8.87B
| $249K | ﹤0.01% |
7,217
-6,460
| -47% | -$231K |
|
2357
Rush Enterprises Class B
RUSHB
$9.37B
| $249K | ﹤0.01% |
12,683
+10,408
| +457% | +$190K |
|
2358
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.3B
| $249K | ﹤0.01% |
+1,385
| New | +$244K |
|
2359
Waters Corp
WAT
$40.6B
| $249K | ﹤0.01% |
1,272
-2,633
| -67% | -$547K |
|
|
ELAT
2360
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $249K | ﹤0.01% |
5,607
+3,372
| +151% | +$142K |
|
|
ACC
2361
DELISTED
American Campus Communities, Inc.
ACC
| $249K | ﹤0.01% |
7,117
-6,855
| -49% | -$236K |
|
2362
Camden National
CAC
$996M
| $248K | ﹤0.01% |
8,204
+6,127
| +295% | +$198K |
|
2363
Ceco Environmental
CECO
$4.5B
| $248K | ﹤0.01% |
33,978
+27,241
| +404% | +$206K |
|
2364
Gen Digital
GEN
$17.7B
| $248K | ﹤0.01% |
11,858
-135,058
| -92% | -$2.92M |
|
2365
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$16.1B
| $248K | ﹤0.01% |
+3,640
| New | +$244K |
|
2366
International Money Express
IMXI
$353M
| $248K | ﹤0.01% |
17,269
+12,893
| +295% | +$197K |
|
2367
The Joint Corp
JYNT
$119M
| $248K | ﹤0.01% |
14,249
+11,475
| +414% | +$187K |
|
2368
Raymond James Financial
RJF
$34.8B
| $248K | ﹤0.01% |
5,109
+997
| +24% | +$48.3K |
|
|
VAR
2369
DELISTED
Varian Medical Systems, Inc.
VAR
| $248K | ﹤0.01% |
1,444
+233
| +19% | +$36.6K |
|
|
AIV
2370
Aimco
AIV
$379M
| $247K | ﹤0.01% |
55,077
-32,009
| -37% | -$155K |
|
2371
Keros Therapeutics
KROS
$211M
| $247K | ﹤0.01% |
6,399
+6,052
| +1,744% | +$240K |
|
|
OCFT
2372
DELISTED
OneConnect Financial Technology
OCFT
| $247K | ﹤0.01% |
+1,162
| New | +$252K |
|
2373
ProShares UltraShort Real Estate
SRS
$15.7M
| $247K | ﹤0.01% |
2,083
+1,078
| +107% | +$129K |
|
2374
ANI Pharmaceuticals
ANIP
$1.72B
| $246K | ﹤0.01% |
8,733
+7,132
| +445% | +$212K |
|
2375
Caesarstone
CSTE
$105M
| $246K | ﹤0.01% |
25,189
+19,292
| +327% | +$208K |
|
Similar funds
CA
ICP
AP
BWA
JSW
SP
GCM
ZP
Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review
As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.
- Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
- Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
- Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
- Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
- Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
- Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
- Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.